Shiro Ueda

3.3k total citations
111 papers, 2.7k citations indexed

About

Shiro Ueda is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Shiro Ueda has authored 111 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Nephrology and 15 papers in Surgery. Recurrent topics in Shiro Ueda's work include Renal Diseases and Glomerulopathies (13 papers), Nephrotoxicity and Medicinal Plants (10 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Shiro Ueda is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Nephrotoxicity and Medicinal Plants (10 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Shiro Ueda collaborates with scholars based in Japan, United States and Taiwan. Shiro Ueda's co-authors include Keiko Kashiwagi, Kazuei Igarashi, Kaori Sakata, Shahana Sharmin, Nobunori Satoh, Makoto Ogawa, Kenji Nishio, Yasuhiro Akai, K Iesato and M Wakashin and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Hepatology.

In The Last Decade

Shiro Ueda

105 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiro Ueda Japan 25 871 427 359 354 338 111 2.7k
Vladisav Stefanović Serbia 29 756 0.9× 430 1.0× 198 0.6× 140 0.4× 386 1.1× 153 2.9k
Juerg Nussberger Switzerland 28 755 0.9× 109 0.3× 307 0.9× 145 0.4× 305 0.9× 72 4.2k
Eberhard Wieland Germany 38 1.2k 1.3× 197 0.5× 535 1.5× 239 0.7× 911 2.7× 132 4.6k
Derek Maclean United Kingdom 31 1.2k 1.4× 259 0.6× 323 0.9× 119 0.3× 351 1.0× 85 2.9k
Frank D. Sistare United States 33 1.9k 2.1× 123 0.3× 306 0.9× 327 0.9× 299 0.9× 109 3.9k
Francisco J. López‐Hernández Spain 28 1.1k 1.3× 181 0.4× 311 0.9× 380 1.1× 268 0.8× 104 3.9k
Edward J. Kelly United States 35 1.1k 1.3× 95 0.2× 113 0.3× 556 1.6× 218 0.6× 96 3.5k
Tsutomu Sakuma Japan 32 705 0.8× 507 1.2× 132 0.4× 498 1.4× 418 1.2× 171 2.9k
Roland Valdes United States 29 840 1.0× 352 0.8× 94 0.3× 571 1.6× 192 0.6× 77 2.8k
Tsutomu Inoue Japan 33 1.8k 2.1× 312 0.7× 251 0.7× 118 0.3× 396 1.2× 185 4.9k

Countries citing papers authored by Shiro Ueda

Since Specialization
Citations

This map shows the geographic impact of Shiro Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Ueda more than expected).

Fields of papers citing papers by Shiro Ueda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Ueda. The network helps show where Shiro Ueda may publish in the future.

Co-authorship network of co-authors of Shiro Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Ueda. A scholar is included among the top collaborators of Shiro Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Ueda. Shiro Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeuchi, Noriko, Makoto Ogawa, Satoshi Suzuki, et al.. (2010). Doubling of serum creatinine: is it appropriate as the endpoint for CKD? Proposal of a new surrogate endpoint based on the reciprocal of serum creatinine. Clinical and Experimental Nephrology. 15(1). 100–107. 2 indexed citations
2.
Sakurada, Tomoya, et al.. (2010). Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients. Pharmacy World & Science. 32(6). 737–743. 4 indexed citations
3.
Hamano, Yuki, Takahiro Aoki, Ryota Shirai, et al.. (2009). Low-Dose Darbepoetin α Attenuates Progression of a Mouse Model of Aristolochic Acid Nephropathy through Early Tubular Protection. Nephron Experimental Nephrology. 114(2). e69–e81. 18 indexed citations
4.
Watanabe, Shinichi, et al.. (2008). Regulation of the statements in the information on drug metabolizing enzyme in the package insert--the present regulation and its history in Japan, the U.S. and the U.K.. PubMed. 43(2). 175–80. 1 indexed citations
5.
Sato, Noriko, et al.. (2007). Effects of Bupleurum scorzoneraefolium, Bupleurum falcatum, and saponins on nephrotoxic serum nephritis in mice. Journal of Ethnopharmacology. 116(3). 397–402. 19 indexed citations
6.
Morimoto, Kaori, Shiro Ueda, Naohiko Seki, et al.. (2005). OATP-C(OATP01B1)*15 is associated with statin-induced myopathy in hypercholesterolemic patients. Clinical Pharmacology & Therapeutics. 77(2). P21–P21. 23 indexed citations
7.
Sugai, Takao, Hiroyuki Hirasawa, Shigeto Oda, et al.. (2005). Prediction of iopromide reduction rates during haemodialysis using an in vitro dialysis system. Nephrology Dialysis Transplantation. 20(4). 754–759. 3 indexed citations
8.
Satoh, S., et al.. (2004). Effect of zaprinast on nitric oxide levels in serum and aortictissue. Methods and Findings in Experimental and Clinical Pharmacology. 26(1). 19–19. 5 indexed citations
9.
Sakata, Kaori, Keiko Kashiwagi, Shahana Sharmin, et al.. (2003). Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochemical and Biophysical Research Communications. 305(1). 143–149. 127 indexed citations
10.
Chen, Shih‐Ming, et al.. (2002). Induction of Nephrotoxic Serum Nephritis in Inbred Mice and Suppressive Effect of Colchicine on the Development of this Nephritis. Pharmacological Research. 45(4). 319–324. 18 indexed citations
11.
12.
Ueda, Shiro, Kenji Nishio, Naoto Minamino, et al.. (1999). Increased Plasma Levels of Adrenomedullin in Patients with Systemic Inflammatory Response Syndrome. American Journal of Respiratory and Critical Care Medicine. 160(1). 132–136. 157 indexed citations
13.
Nishio, Kenji, Yasuhiro Akai, Yoshinori Murao, et al.. (1997). Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Critical Care Medicine. 25(6). 953–957. 152 indexed citations
14.
Yoshida, Hiromichi, Shiro Ueda, Ryosaku Azemoto, et al.. (1990). Detection of nephritogenic antigen from the Lewis rat renal tubular basement membrane. Kidney International. 37(5). 1286–1294. 8 indexed citations
15.
Takagi, Nobuyoshi, H. Oda, Yasuo Tokita, et al.. (1989). Changes of the Serum Amikacin (AMK) Level in Patients with Serious Acute Renal Failure Treated by Continuous Arteriovenous Hemofiltration (CAVH). Artificial Organs. 13(3). 238–241. 2 indexed citations
16.
Mori, Yoshio, Makoto Ogawa, Teruo Mori, et al.. (1987). Study of cellular inetractions in experimental autoimmune hepatitis in mice.. Kanzo. 28(3). 283–290. 1 indexed citations
17.
Sasaki, Yoshinori & Shiro Ueda. (1978). A Study of High-Temperature Phosphidation of Metallic Chromium. NIPPON KAGAKU KAISHI. 956–959. 1 indexed citations
18.
Nozaki, Fumio, Toshio Itoh, & Shiro Ueda. (1973). Catalytic Activity of Zirconium Phosphate for Dehydration of 2-Propanol. NIPPON KAGAKU KAISHI. 674–678. 6 indexed citations
19.
Ueda, Shiro, et al.. (1963). Studies on Condenced Phosphates Containing Nitrogen. I-II. II. Properties of Ammonium Polyphosphate. The Journal of the Society of Chemical Industry Japan. 66(5). 589–592. 4 indexed citations
20.
Ueda, Shiro, et al.. (1963). Studies on Condenced Phosphates Containing Nitrogen. I-II. I. Formation of Ammonium Polyphosphate. The Journal of the Society of Chemical Industry Japan. 66(5). 586–589. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vladisav Stefanović Breakdown of academic impact, for papers by Juerg Nussberger Breakdown of academic impact, for papers by Eberhard Wieland Breakdown of academic impact, for papers by Derek Maclean Breakdown of academic impact, for papers by Frank D. Sistare Breakdown of academic impact, for papers by Francisco J. López‐Hernández Breakdown of academic impact, for papers by Edward J. Kelly Breakdown of academic impact, for papers by Tsutomu Sakuma Breakdown of academic impact, for papers by Roland Valdes Breakdown of academic impact, for papers by Tsutomu Inoue
Rankless by CCL
2026